Weed (BUDZ) Operating Expenses (2010 - 2026)
Weed's (BUDZ) quarterly Operating Expenses came in at $163955.0 in Q1 2026, down 62.29% year-on-year from $434737.0 in Q1 2025, and down 77.44% quarter-over-quarter from $726874.0 in Q4 2025.
Weed (BUDZ) Operating Expenses (2010 - 2026) Analysis & Trends
Weed's Operating Expenses history runs 13 years deep, the most recent figure standing at $163955.0 for Q1 2026.
- On a quarterly basis, Operating Expenses fell 62.29% year-over-year to $163955.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 31.5% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 150.51% from the prior year.
- Operating Expenses slipped to $163955.0 in Q1 2026 per BUDZ's latest filing, from $726874.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $726874.0 in Q4 2025 and bottomed at $66897.0 in Q3 2025.
- The 5-year median for Operating Expenses is $183908.0 (2023), against an average of $252641.5.
- Across the five-year window, Operating Expenses tumbled 66.27% in 2022 and jumped 470.27% in 2025, its largest moves.
- Year by year, Operating Expenses stood at $291091.0 in 2022, then plunged by 34.15% to $191673.0 in 2023, then slumped by 33.5% to $127462.0 in 2024, then soared by 470.27% to $726874.0 in 2025, then plunged by 77.44% to $163955.0 in 2026.
- Per Business Quant, the three latest BUDZ Operating Expenses figures stand at $163955.0 (Q1 2026), $726874.0 (Q4 2025), and $66897.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Weed | 2.73 Mn | 2.73 Mn | - | 163,955.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,955.00 |
| Dec 31, 2025 | 726,874.00 |
| Sep 30, 2025 | 66,897.00 |
| Jun 30, 2025 | 94,045.00 |
| Mar 31, 2025 | 434,737.00 |
| Dec 31, 2024 | 127,462.00 |
| Sep 30, 2024 | 92,649.00 |
| Jun 30, 2024 | 144,955.00 |
| Mar 31, 2024 | 167,489.00 |
| Dec 31, 2023 | 191,673.00 |
| Sep 30, 2023 | 238,824.00 |
| Jun 30, 2023 | 156,163.00 |
| Mar 31, 2023 | 183,908.00 |
| Dec 31, 2022 | 291,091.00 |
| Sep 30, 2022 | 275,730.00 |
| Jun 30, 2022 | 407,313.00 |
| Mar 31, 2022 | 531,140.00 |
| Dec 31, 2021 | 461,338.00 |
| Sep 30, 2021 | 169,910.00 |
| Jun 30, 2021 | 1.21 Mn |